Facebook
Twitter
Telegram
Fehler meldenX4 Pharmaceuticals Kennzahlen 2011-2024 | XFOR
Kennzahlen Jährlich X4 Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.3 | -0.6 | -0.6 | -2.5 | -1.9 | -0.9 | -0.8 | - | - | - | - | - | - |
P/S |
- | - | - | 52.3 | - | 11.4 | - | - | - | - | - | - | - |
EPS |
-0.6 | -1.5 | -4.0 | -3.1 | -4.6 | -79.2 | -54.6 | -44.8 | - | - | - | - | - |
EV (Enterprise Value) |
230 M | 15.1 M | 24 M | 128 M | 4.45 M | 46.3 M | 22.9 M | 60.7 M | 43.8 M | - | - | - | - |
EBITDA per Share |
-0.6 | -1.37 | -3.29 | -2.96 | -4.14 | -17.8 | -92.7 | - | - | - | - | - | - |
EV/EBITDA |
-0.3 | -1.9 | 0.1 | -0.4 | 1.3 | - | - | - | - | - | - | ||
PEG |
- | -0.08 | -0.03 | -0.01 | 0.01 | - | - | - | - | - | - | ||
P/B |
4.6 | 0.7 | 0.8 | 2.2 | 0.8 | 1.9 | 0.5 | - | - | - | - | - | - |
P/CF |
-2.4 | -0.7 | -0.7 | -2.7 | -2.1 | -1.0 | -1.0 | - | - | - | - | - | - |
ROE % |
-197.98 | -126.76 | -137.70 | -85.35 | -40.87 | -199.17 | -57.71 | - | - | - | - | - | - |
ROA % |
-68.70 | -60.33 | -75.69 | -50.57 | -32.86 | -119.49 | -41.69 | - | - | - | - | - | - |
ROCE % |
-210.42 | -118.25 | -132.13 | -82.25 | -31.61 | -139.53 | -45.72 | - | - | - | - | - | - |
Current Ratio |
1.5 | 1.9 | 2.2 | 2.5 | 13.7 | 6.5 | 7.4 | - | - | - | - | - | - |
DSO |
- | - | - | - | - | 298.2 | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Kennzahlen Vierteljährlich X4 Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.26 | - | -0.01 | -0.33 | -0.16 | - | -0.26 | -0.6 | -0.72 | - | -0.76 | -0.74 | -1.3 | - | -0.87 | -0.76 | -0.56 | - | -1.22 | -1.02 | -6.67 | -0.65 | -20.39 | -14.83 | -17.7 | -1.68 | -22.6 | -11.13 | -10.49 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.19 | - | - | - | -0.2 | - | -0.24 | -0.58 | -0.63 | - | -0.7 | -0.72 | -0.86 | - | -0.83 | -0.73 | -0.53 | - | -1.16 | -1.01 | -6.06 | - | -18.4 | -13.8 | -13.3 | - | -25.1 | -10.8 | -11.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-5086.03 | -132.39 | -167.29 | -198.78 | -186.82 | -149.62 | -178.99 | -173.47 | -125.42 | -69.64 | -93.61 | -88.20 | -86.52 | -60.07 | -73.78 | -63.52 | -53.07 | -32.48 | -20.34 | 4.53 | 22.71 | 40.68 | 53.66 | 22.74 | 5.19 | -13.54 | -38.65 | -18.89 | -9.17 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-80.93 | -52.77 | -71.80 | -89.51 | -79.42 | -63.13 | -79.87 | -55.53 | -69.39 | -42.20 | -56.40 | -53.86 | -52.32 | -35.59 | -46.61 | -43.44 | -39.44 | -26.12 | -120.22 | -195.71 | -248.06 | -315.38 | -235.04 | -162.81 | -109.15 | -41.69 | -27.92 | -13.65 | -6.63 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-3718.06 | -135.18 | -167.76 | -160.09 | -190.28 | -143.77 | -171.60 | -166.86 | -120.21 | -66.66 | -89.99 | -85.47 | -83.86 | -57.99 | -71.13 | -60.94 | -51.19 | -31.60 | -20.51 | 3.71 | 22.36 | 27.28 | 5.04 | -28.28 | -46.17 | -41.78 | -41.78 | -19.54 | -9.93 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.0 | 1.5 | 1.6 | 1.6 | 1.7 | 1.9 | 2.2 | - | 2.0 | 2.2 | 2.3 | 2.7 | 3.0 | 2.5 | 2.5 | 2.5 | 2.5 | 5.1 | 5.1 | 5.1 | 5.1 | 0.5 | 0.5 | 0.5 | 0.5 | 3.6 | 3.6 | 3.6 | 3.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung